Clinical Trials Browser

Completed × Interventional × ulixertinib × Clear all

NCT04145297 2024-11-18

UTAH

Phase 1 Completed

Gastrointestinal

Gastrointestinal Neoplasms

NCT02296242 2019-01-29

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

Phase 1/2 Completed

53 enrolled 16 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute